Defining Success: Insights From a Random Assignment, Multisite Study of Implementing HIV Prevention, Testing, and Linkage to Care in U.S. Jails and Prisons.
In the emerging field of implementation science, measuring the extent to which a new or modified healthcare program or practice is successfully implemented following an intervention is a critical component in understanding how evidence-based treatments become part of regular practice. This paper is intended to expand our understanding of factors that influence the successful adoption of new or modified HIV services in correctional settings. The nine-site project developed and directed an organization-level intervention designed to implement improvements in preventing, detecting, and treating HIV for persons under correctional supervision. Using semi-structured interviews to elicit perceptions from Senior Researchers and Executive Sponsors at each of the nine sites, this paper presents their views and observations regarding the success of the experimental intervention in their criminal justice setting. Within the areas of focus for implementation (either HIV prevention, testing, or linkage to community treatment) the complexity of programmatic needs was very influential with regards to perceptions of success. An organization's pre-existing characteristics, staffing, funding, and interorganizational relationships contributed to either the ease or difficulty of programmatic implementation. Results are discussed pertaining to furthering our understanding of why new or modified healthcare interventions achieve success, including whether the intervention is a modification of existing practice or is a new intervention, and the choice of implementation strategy.
Friends Research Institute, Inc., Baltimore, Maryland.
Shannon Gwin
SG
Mitchell
University of Connecticut, West Hartford, Connecticut.
Jennifer
J
Willett
Abt Associates, Inc., Cambridge, Massachusetts.
Holly
H
Swan
Friends Research Institute, Inc., Baltimore, Maryland.
Laura B
LB
Monico
University of Louisiana at Lafayette, Lafayette, Louisiana.
Yang
Y
Yang
University of Connecticut, West Hartford, Connecticut.
Yvonne O
YO
Patterson
Temple University, Philadelphia, Pennsylvania.
Steven
S
Belenko
Friends Research Institute, Inc., Baltimore, Maryland.
Robert P
RP
Schwartz
University of Delaware, Newark, Delaware.
Christy A
CA
Visher
D044966:Anti-Retroviral Agents / Q000008:administration & dosage; D003266:Continuity of Patient Care / Q000458:organization & administration*; D003695:Delivery of Health Care / Q000458:organization & administration*; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000517:prevention & control* / Q000628:therapy*; D006266:Health Education / Q000458:organization & administration; D006284:Health Plan Implementation / Q000458:organization & administration*; D006291:Health Policy; D006298:Health Services Administration; D006801:Humans; D007407:Interviews as Topic; D008297:Male; D008403:Mass Screening / Q000458:organization & administration*; D011330:Prisons / Q000458:organization & administration*; D036301:Qualitative Research; D014481:United States
D044966:Anti-Retroviral Agents